Canada approves Moderna's RSV vaccine for adults aged 60 and older
Adds details and background in paragraphs 2-8
Nov 8 (Reuters) -Moderna MRNA.O said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years and older, making it the country's first authorised mRNA-based shot for the condition.
Health Canada has approved the vaccine, mRESVIA, for prevention of lower respiratory tract disease in older adults, the company said, adding that its supply is expected in early 2025.
mRNA vaccines, which teach the body to make specific proteins that the immune system can recognize and attack, have the potential to treat multiple diseases and be more effective than conventional shots, the company said.
Earlier this week, British drugmaker GSK GSK.L received approval in Canada for its RSV vaccine for adults aged between 50 and 59 years.
GSK's Arexvy and Pfizer PFE.N's shot Abrysvo, both protein-based vaccines, are also approved in Canada for adults aged 60 years and older.
Moderna's shot was approved in the United States in May for the same age group. It is also approved in Europe and Qatar.
The Cambridge, Massachusetts-based company has been banking on revenue from newer mRNA shots, including mRESVIA and an experimental COVID-flu combination vaccine, to make up for waning post-pandemic demand for COVID products.
RSV, which typically causes cold-like symptoms, is a leading cause of pneumonia in toddlers and older adults.
Reporting by Bhanvi Satija in Bengaluru; Editing by Shilpi Majumdar
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
